Daily

Brace for impact on Celladon, a hospital is giving out Apple Watches (Morning Read)

Hospitals already handing out Apple Watches? Will Celladon’s stumble mean pain for other hot gene-therapy stocks? Also, talk about Theranos, Bristol-Myers Squibb and pending CMS penalties all in today’s Morning Read.

TOP STORIES

Look beyond the simple disaster that will be Celladon, which announced its heart failure treatment, Mydicar, slumped in clinical trials. What will it do to stocks like Bluebird Bio, UniQure or Spark Therapeutics?

Oschner Health System is giving Apple Watches to patients with high-blood-pressure problems.

You saw it coming: “Nearly 40% of doctors, other providers with Medicare patients will have payments docked 1.5% this year after failing to submit data,” CMS says.

LIFE SCIENCE

Is it Theranos backlash? Or is it something worse?

Bristol-Myers Squibb’s daclatasvir helps cure hepatitis C in 90 percent of patients when paired with Sovaldi and ribavirin. Now what’s the price tag?

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

Stempeutics’ stem cell drug Stempeucel is the first company to get a process patient for a stem-cell treatment in China

Here are the 11 drugs, including Bristol-Myers Squibb’s melanoma treatment Opdivo, that are recommended for approval in Europe.

PAYERS-PROVIDERS

Public health officials are moving quickly on the latest strain of bird flu.

More tangible evidence of what we’re missing because of underfunded research.

A healthcare hero in Nepal. Cardiologist Ellen Gallant stepped in to help earthquake victims.

The end of pimping as we know it?

Critics say med students can’t possibly master so much information, which quickly becomes outdated anyway. Instead, the new theory goes, students should be taught and evaluated on their ability to find, assess and synthesize knowledge. And they should be educated in teams to help prepare them for what goes on in the real world.

TECH

The Apple Watch includes deactivated oxygen sensors.

Sadness in Nepal. Google X’s privacy lead Dan Fredinburg was killed in the earthquake.

POLITICS

American elections will have Obamacare. In the U.K., it’s the National Health Service under voter scrutiny.

A LITTLE EXTRA

Savor the Hubble anniversary with amazing photos and this latest eye candy, published last week.

The Morning Read provides a 24-hour wrap up of everything else healthcare’s innovators need to know about the business of medicine (and beyond). The author of The Read published it but all full-time MedCity News journalists contribute to its content.

Topics